Annual conference on immunology and microbiology in Colorado
Official title: Colorado Immunology and Microbiology Conference (CIMC)
Funded at University of Colorado Denver · NIH-10904824 · Data updated 2026-11-12
The Colorado Immunology and Microbiology Conference brings together top scientists and new researchers to share the latest discoveries about the immune system and germs, focusing on important health topics like cancer and diabetes, so everyone can learn and work together to improve human health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | August 10, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $4,000 |
| NIH project number | 5R13AI179153-02 |
| Project ID | NIH-10904824 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals affected by autoimmune diseases or those interested in the latest developments in immunology and microbiology.
✕Less likely to help
Patients who are not interested in scientific discussions or who do not have conditions related to immunology or microbiology may not receive direct benefits from this conference.
What this research studies
The Colorado Immunology and Microbiology Conference (CIMC) aims to gather leading scientists and emerging researchers to discuss the latest advancements in immunology and microbiology. This annual event features presentations on various topics, including cancer immunology, diabetes, autoimmunity, and microbial pathogenesis. Attendees will have the opportunity to engage in discussions about unpublished research and its implications for human health. The conference fosters collaboration and knowledge sharing among professionals in the field.
Why it matters
Potential benefit: If successful, this conference could lead to new insights and advancements in the treatment of autoimmune diseases and infectious conditions.
How similar studies have gone: Previous conferences in this field have successfully facilitated collaboration and innovation, indicating that this approach is effective in advancing research.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Doran, Kelly S — University of Colorado Denver
- Study coordinator: Doran, Kelly S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.